It is noteworthy that the association of high NCOR2 levels with a favourable outcome in breast cancer patients seems to be in conflict with our cell line data, which showed increased NCOR2 mRNA and protein levels in tamoxifen-resistant cell lines (Figure 1 and Supplementary Figure S3). The gene discussed is NCOR2; the disease is breast cancer.